Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Validation of an Algorithm for Semi-automated Estimation of Voice Relative Fundamental Frequency.

Lien YS, Heller Murray ES, Calabrese CR, Michener CM, Van Stan JH, Mehta DD, Hillman RE, Noordzij JP, Stepp CE.

Ann Otol Rhinol Laryngol. 2017 Oct;126(10):712-716. doi: 10.1177/0003489417728088. Epub 2017 Aug 29.

2.

Voice Relative Fundamental Frequency Via Neck-Skin Acceleration in Individuals With Voice Disorders.

Lien YA, Calabrese CR, Michener CM, Murray EH, Van Stan JH, Mehta DD, Hillman RE, Noordzij JP, Stepp CE.

J Speech Lang Hear Res. 2015 Oct;58(5):1482-7. doi: 10.1044/2015_JSLHR-S-15-0126.

3.

Effects of Adventitious Acute Vocal Trauma: Relative Fundamental Frequency and Listener Perception.

Murray ES, Hands GL, Calabrese CR, Stepp CE.

J Voice. 2016 Mar;30(2):177-85. doi: 10.1016/j.jvoice.2015.04.005. Epub 2015 May 28.

4.

Dietary modulation of the microbiome affects autoinflammatory disease.

Lukens JR, Gurung P, Vogel P, Johnson GR, Carter RA, McGoldrick DJ, Bandi SR, Calabrese CR, Vande Walle L, Lamkanfi M, Kanneganti TD.

Nature. 2014 Dec 11;516(7530):246-9. doi: 10.1038/nature13788. Epub 2014 Sep 28.

5.

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Boulos N, Mulder HL, Calabrese CR, Morrison JB, Rehg JE, Relling MV, Sherr CJ, Williams RT.

Blood. 2011 Mar 31;117(13):3585-95. doi: 10.1182/blood-2010-08-301267. Epub 2011 Jan 24.

6.

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.

Thomas HD, Calabrese CR, Batey MA, Canan S, Hostomsky Z, Kyle S, Maegley KA, Newell DR, Skalitzky D, Wang LZ, Webber SE, Curtin NJ.

Mol Cancer Ther. 2007 Mar;6(3):945-56.

7.

Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.

Tikhe JG, Webber SE, Hostomsky Z, Maegley KA, Ekkers A, Li J, Yu XH, Almassy RJ, Kumpf RA, Boritzki TJ, Zhang C, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang LZ, Calvert AH, Golding BT, Griffin RJ, Newell DR.

J Med Chem. 2004 Oct 21;47(22):5467-81.

PMID:
15481984
8.

Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.

Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan-Koch S, Durkacz BW, Hostomsky Z, Kumpf RA, Kyle S, Li J, Maegley K, Newell DR, Notarianni E, Stratford IJ, Skalitzky D, Thomas HD, Wang LZ, Webber SE, Williams KJ, Curtin NJ.

J Natl Cancer Inst. 2004 Jan 7;96(1):56-67.

PMID:
14709739
9.

Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies.

Calabrese CR, Batey MA, Thomas HD, Durkacz BW, Wang LZ, Kyle S, Skalitzky D, Li J, Zhang C, Boritzki T, Maegley K, Calvert AH, Hostomsky Z, Newell DR, Curtin NJ.

Clin Cancer Res. 2003 Jul;9(7):2711-8.

10.

Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.

Canan Koch SS, Thoresen LH, Tikhe JG, Maegley KA, Almassy RJ, Li J, Yu XH, Zook SE, Kumpf RA, Zhang C, Boritzki TJ, Mansour RN, Zhang KE, Ekker A, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang LZ, Calvert AH, Golding BT, Griffin RJ, Newell DR, Webber SE, Hostomsky Z.

J Med Chem. 2002 Nov 7;45(23):4961-74.

PMID:
12408707
11.

Separation methods for anthraquinone related anti-cancer drugs.

Loadman PM, Calabrese CR.

J Chromatogr B Biomed Sci Appl. 2001 Nov 25;764(1-2):193-206. Review.

PMID:
11817028
12.

In vivo metabolism of the antitumor imidazoacridinone C1311 in the mouse and in vitro comparison with humans.

Calabrese CR, Loadman PM, Lim LS, Bibby MC, Double JA, Brown JE, Lamb JH.

Drug Metab Dispos. 1999 Feb;27(2):240-5.

PMID:
9929509
13.

Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice.

Calabrese CR, Bibby MC, Double JA, Loadman PM.

Cancer Chemother Pharmacol. 1998;42(5):379-85.

PMID:
9771952
14.

Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.

Calabrese CR, Loadman PM.

J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):275-81.

PMID:
9106053

Supplemental Content

Loading ...
Support Center